Targeting EGFR in head and neck cancer: a decade of progress

Nat Clin Pract Oncol. 2009 Mar;6(3):123. doi: 10.1038/ncponc1328.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / economics
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cetuximab
  • Cisplatin / administration & dosage
  • Clinical Trials as Topic
  • ErbB Receptors / drug effects*
  • Fluorouracil / administration & dosage
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / economics
  • Head and Neck Neoplasms / metabolism*
  • Humans
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • ErbB Receptors
  • Cetuximab
  • Cisplatin
  • Fluorouracil